The chief executive of the German firm BioNTech, Ugur Sahin, said in an interview published in The Wall Street Journal on Friday that the company is confident of obtaining regulatory approval for a covid-19 vaccine by the end of the year. However, Sahin said it will take a decade to see its immunity effects.
BioNTech: cautious optimism about the possible vaccine
2020-07-11T07:50:33.024Z
The chief executive of the German firm BioNTech, Ugur Sahin, said this Friday in an interview published in The Wall Street Journal that the company is confident of obtaining regulatory approval ...
